­
Blog Archives - Page 23 of 79 - NFCR

Blog

Catching Cancer Cells on Their Way to Spreading

NEW NFCR-Supported Technology is Ready for Clinical Use With a better understanding of the genetic changes in cancer cells, and a more effective way to capture them, oncologists and scientists can be alerted to drug resistance and metastasis —allowing them to more quickly select new drugs or better therapies for…...

Read more

3 Important Tips For Immuno-Oncology Drug Treatment

Immuno-oncology (IO) drugs have demonstrated unprecedented benefits in the treatment of several types of cancer. The overall survival time of cancer patients treated by IO drugs have been dramatically extended, and in some cases, even late stage fatal cancers are brought into remission by the IO-based immunotherapy. IO drugs work…...

Read more

Cancer Research Applied to Develop COVID-19 Treatment Strategies

New publication by NFCR-supported scientist Rakesh Jain, Ph.D., applies cancer research findings to help COVID-19 treatment in different patient groups. Few drugs for COVID-19 appear to work well in unselected patients, but now a new mathematical model provides insight into which patients benefit from which treatments. Researchers and investigators, including…...

Read more

The Benefits of Juicing: Fact vs Fiction

No matter who you are or where you live, everyone can benefit by following one simple rule: eat more vegetables! This simple yet important rule often has a huge following in the beginning of a new year as many people are resolute to eat healthier and exercise more. In fact,…...

Read more

Cancer Patients and the Flu: What You Need to Know

The COVID-19 pandemic has not replaced the risks posed by the seasonal flu. Learn why the influenza virus is particularly dangerous for cancer patients and how to keep yourself and your loved ones safe.  With so much attention focused on the ongoing COVID-19 pandemic, it can be easy for us…...

Read more

Biosimilar Drugs: Lowering the Cost of Cancer Care?

The National Foundation for Cancer Research (NFCR) answers some of the most frequently asked questions about biosimilar drugs for cancer treatment. Biologic drugs (biologics) are a special class of medications that are made from living organisms, such as proteins.1 Vaccines, hormones, and anti-allergy medications are all examples of biologics.2 These…...

Read more

Stay Strong, Be Positive: Brianne’s Story

Sometimes life gets busy and all you can do is put your head down and focus. That was what the autumn of 2017 looked like for Brianne Jaeger. She was a busy mother of two in her mid-thirties juggling her office manager role and a busy social life. That autumn…...

Read more

2019 Salisbury Award Winners

Johns Hopkins researchers Emily Han-Chung Hsiue, M.D., and Jacqueline Douglass in the Vogelstein/Kinzler Lab at the Sidney Kimmel Comprehensive Cancer Center have been researching MANAbodies, an entirely novel immunotherapeutic approach which could be a significant weapon against cancer and source of hope for patients. MANAbodies are bispecific antibodies that target…...

Read more

NEW Cervical Cancer Screening Guidelines

Buried amongst the pandemic commotion was American Cancer Society’s newest cervical cancer screening guidelines. Cervical cancer affects women of all ages worldwide and is often dubbed ‘the silent killer’ as it presents with no symptoms in the early stages. Luckily there is an effective screening method to help reduce the…...

Read more

10 Ways to Embrace Positivity in 2021

As Americans gathered around to watch the annual ball drop, most people were relieved to finally bid farewell to the unprecedented year of 2020. The year had been exceptionally challenging in every way imaginable – financially, physically, mentally, and emotionally. Though it was truly amazing to see people and organizations…...

Read more